1. Home
  2. EEIQ vs BOLT Comparison

EEIQ vs BOLT Comparison

Compare EEIQ & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

HOLD

Current Price

$3.11

Market Cap

7.8M

Sector

Real Estate

ML Signal

HOLD

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

HOLD

Current Price

$4.96

Market Cap

7.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEIQ
BOLT
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
7.7M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
EEIQ
BOLT
Price
$3.11
$4.96
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $41.00
AVG Volume (30 Days)
6.0K
★ 705.5K
Earning Date
06-25-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $7,695,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 0.07
52 Week Low
$0.15
$5.06
52 Week High
$12.70
$14.40

Technical Indicators

Market Signals
Indicator
EEIQ
BOLT
Relative Strength Index (RSI) 28.64 28.59
Support Level $2.85 N/A
Resistance Level $3.82 $8.72
Average True Range (ATR) 0.22 0.39
MACD -0.09 -0.12
Stochastic Oscillator 20.15 4.28

Price Performance

Historical Comparison
EEIQ
BOLT

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S, Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. The Company's revenue is derived from foreign education programs, university education programs and student accommodation services.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

Share on Social Networks: